Rare diseases
Investigational molecules
Locations
Study of Olaparib and Abiraterone for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
FranceStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
FranceStudy of LN-145 (tumor infiltrating lymphocytes) with cyclophosphamide, fludarabine, and aldesleukin in patients with recurrent, metastatic, or persistent cervical cancer
FranceComparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety
FranceStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
FranceStudy of DF6002 alone and combined with nivolumab in patients with advanced solid tumors: A safety and effectiveness trial
FranceStudy on the Safety and Effects of IPH6501 for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma
FranceStudy of Azenosertib (ZN-c3) for Women with Recurrent or Persistent Uterine Serous Carcinoma
FranceStudy on Bomedemstat for Patients with Essential Thrombocythemia Not Responding to or Intolerant of Hydroxyurea, Comparing with a Drug Combination
FranceStudy on Teclistamab and Drug Combination for Newly Diagnosed Multiple Myeloma Patients
FranceStudy of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma
FranceStudy of Tamibarotene, Venetoclax, and Azacitidine for Adults with RARA-positive Acute Myeloid Leukemia Not Eligible for Standard Therapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
